153 related articles for article (PubMed ID: 7686570)
1. Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors.
Altman DA; Nickoloff BJ; Fivenson DP
J Cutan Pathol; 1993 Apr; 20(2):154-8. PubMed ID: 7686570
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles.
Hsi ED; Nickoloff BJ
J Dermatol Sci; 1996 Jan; 11(1):1-9. PubMed ID: 8867761
[TBL] [Abstract][Full Text] [Related]
3. A cutaneous case of giant cell angiofibroma occurring with dermatofibrosarcoma protuberans and showing bimodal CD34+ fibroblastic and FXIIIa+ histiocytic immunophenotype.
Silverman JS; Tamsen A
J Cutan Pathol; 1998 May; 25(5):265-70. PubMed ID: 9696292
[TBL] [Abstract][Full Text] [Related]
4. Fibrohistiocytic differentiation in subcutaneous fatty tumors. Study of spindle cell, pleomorphic, myxoid, and atypical lipoma and dedifferentiated liposarcoma cases composed in part of CD34+ fibroblasts and FXIIIa+ histiocytes.
Silverman JS; Tamsen A
J Cutan Pathol; 1997 Sep; 24(8):484-93. PubMed ID: 9331894
[TBL] [Abstract][Full Text] [Related]
5. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
Abenoza P; Lillemoe T
Am J Dermatopathol; 1993 Oct; 15(5):429-34. PubMed ID: 7694515
[TBL] [Abstract][Full Text] [Related]
6. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
Goldblum JR; Tuthill RJ
Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
[TBL] [Abstract][Full Text] [Related]
7. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
8. Myxoid dermatofibrohistiocytoma: an indolent post-traumatic tumor composed of CD34+ epithelioid and dendritic cells and factor XIIIa+ dendrophages.
Silverman JS; Brustein S
J Cutan Pathol; 1996 Dec; 23(6):551-7. PubMed ID: 9001986
[TBL] [Abstract][Full Text] [Related]
9. Comparison of angiomyofibroblastoma and aggressive angiomyxoma in both sexes: four cases composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets.
Silverman JS; Albukerk J; Tamsen A
Pathol Res Pract; 1997; 193(10):673-82. PubMed ID: 9505259
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
Li N; McNiff J; Hui P; Manfioletti G; Tallini G
Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
[TBL] [Abstract][Full Text] [Related]
12. Oral submucosal dendrocytes: factor XIIIa+ and CD34+ dendritic cell populations in normal tissue and fibrovascular lesions.
Regezi JA; Nickoloff BJ; Headington JT
J Cutan Pathol; 1992 Oct; 19(5):398-406. PubMed ID: 1282135
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
West KL; Cardona DM; Su Z; Puri PK
Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas.
Prieto VG; Reed JA; Shea CR
J Cutan Pathol; 1995 Aug; 22(4):336-41. PubMed ID: 7499573
[TBL] [Abstract][Full Text] [Related]
15. Epithelioid cell histiocytoma--histogenetic and kinetics analysis of dermal microvascular unit dendritic cell subpopulations.
Silverman JS; Glusac EJ
J Cutan Pathol; 2003 Aug; 30(7):415-22. PubMed ID: 12859738
[TBL] [Abstract][Full Text] [Related]
16. Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34.
Mahmood MN; Salama ME; Chaffins M; Ormsby AH; Ma CK; Linden MD; Lee MW
J Cutan Pathol; 2003 Nov; 30(10):631-6. PubMed ID: 14744088
[TBL] [Abstract][Full Text] [Related]
17. Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans: a comparison with fibroblast and endothelial cells of the dermis.
Bonish BK; Foreman KE; Gutierrez-Steil C; Nickoloff BJ
J Dermatol Sci; 1997 Nov; 16(1):52-8. PubMed ID: 9438908
[TBL] [Abstract][Full Text] [Related]
18. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34.
Aiba S; Tabata N; Ishii H; Ootani H; Tagami H
Br J Dermatol; 1992 Aug; 127(2):79-84. PubMed ID: 1382538
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous expression of Thy-1 in mycosis fungoides.
Fivenson DP; Douglass MC; Nickoloff BJ
Am J Pathol; 1992 Dec; 141(6):1373-80. PubMed ID: 1281618
[TBL] [Abstract][Full Text] [Related]
20. An unusual soft tissue tumor with features of angiomatoid malignant fibrous histiocytoma composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets. CD34 and factor XIIIa in angiomatoid MFH.
Silverman JS; Lomvardias S
Pathol Res Pract; 1997; 193(1):51-8; discussion 59-60. PubMed ID: 9112273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
